CN102772575B - Traditional Chinese medicine composition for treating chronic hepatitis B - Google Patents

Traditional Chinese medicine composition for treating chronic hepatitis B Download PDF

Info

Publication number
CN102772575B
CN102772575B CN201210293637.5A CN201210293637A CN102772575B CN 102772575 B CN102772575 B CN 102772575B CN 201210293637 A CN201210293637 A CN 201210293637A CN 102772575 B CN102772575 B CN 102772575B
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
radix
chronic hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210293637.5A
Other languages
Chinese (zh)
Other versions
CN102772575A (en
Inventor
刘海霞
张守潘
王晴文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210293637.5A priority Critical patent/CN102772575B/en
Publication of CN102772575A publication Critical patent/CN102772575A/en
Application granted granted Critical
Publication of CN102772575B publication Critical patent/CN102772575B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine composition for treating chronic hepatitis B. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10 parts of radix bupleuri, 10 parts of radix paeoniae rubra, 10 parts of radix paeoniae alba, 5 parts of radix aucklandiae, 5 parts of fructus schisandrae chinensis, 10 parts of rhubarb, 10 parts of herba artemisiae scopariae, 10 parts of fructus lycii, 10 parts of pangolin scales and 15 parts of turtle shell. The traditional Chinese medicine composition provided by the invention has the effects of dispelling pathogen, reinforcing healthy qi and emolliating liver, thus having an obvious curative effect on the chronic hepatitis B.

Description

A kind of Chinese medicine composition for the treatment of chronic hepatitis B
Technical field
The present invention relates to a kind of medicine for the treatment of chronic hepatitis B, be specifically related to a kind of Chinese medicine composition for the treatment of chronic hepatitis B.
Background technology
Chronic hepatitis B is that a kind of sickness rate is high, and the course of disease is long, refractory more, easy commonly encountered diseases repeatedly, the serious health that affects.Doctor trained in Western medicine adopts at present antiviral, immunomodulating, protects the liver, falls the comprehensive drug treatment such as enzyme, antiinflammatory and fibrosis the treatment of primary disease, still, and the problem such as it is high that western modern medicine treatment exists expense, and untoward reaction is many, and therapeutic effect is undesirable; Chinese medicine has outstanding advantage aspect treatment hepatitis B, but the medicine of existing treatment chronic hepatitis B is fewer clinically, more and more can not meet clinical demand.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of chronic hepatitis B.
Technical scheme of the present invention is as follows:
A kind of Chinese medicine composition for the treatment of chronic hepatitis B, it is characterized in that, be prepared from by the crude drug of following weight portion: Radix Bupleuri 10, Radix Paeoniae Rubra 10, the Radix Paeoniae Alba 10, the Radix Aucklandiae 5, Fructus Schisandrae Chinensis 5, Radix Et Rhizoma Rhei 10, Herba Artemisiae Scopariae 10, Fructus Lycii 10, Squama Manis 10, Carapax Trionycis 15.
Take above each taste by proportioning, get 60% ethanol extraction 2 times that Squama Manis, Carapax Trionycis add 8 times, 6 times amounts, each 2 hours, merging filtrate, filters, concentrated, dry, pulverize to obtain alcohol extract, all the other each tastes add the water extraction 2 times of 8 times of amounts at every turn, each 2 hours, merging filtrate, filters, concentrated, after dry, pulverize, mix with alcohol extract.
In side, Radix Bupleuri is evacuated and is brought down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy; Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, Radix Aucklandiae promoting the circulation of QI to relieve pain, invigorating the spleen and regulating the stomach; Fructus Schisandrae Chinensis convergence is astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming; Radix Et Rhizoma Rhei has removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation, effect of dampness removing jaundice eliminating; Herba Artemisiae Scopariae eliminating damp-heat, promoting the function of the gallbladder to alleviate jaundice; Fructus Lycii nourishing the liver and kidney; Squama Manis promoting blood circulation to remove obstruction in the collateral; Carapax Trionycis nourishing YIN for suppressing the hyperactive YANG, brings down a fever except steaming, hard masses softening and resolving.All medicine phases 5, have and get rid of evils, righting, the effect of easing the affected liver.
Clinical data
clinical data
1. diagnostic criteria:
Diagnosis meets " 2010 editions the guidelines " standard of Chinese Medical Association's hepatopathy credit meeting in 2010 and the revision of the sick credit of infection club.
2. clinical efficacy standard:
1) effective: except hepatic facies, liver palm, spider angioma, all the other sings and symptomses significantly take a turn for the better or approach and disappear; Liver function is significantly improved, and even approaches normal; Accompany or do not accompany the improvement of other chemical examinations and auxiliary examination project;
2) effective: the treatment between effective and invalid lapses to;
3) invalid: the index in clinical symptoms, sign, lab testing and auxiliary examination more than 80% is without improvement, even increase the weight of.In practical operation, all between two-stage curative effect person, all include the good one-level of curative effect in, do not repeat to each other statistics.
3. clinical trial:
The chronic hepatitis B patient that we examine between year June in March, 2010 to 2012, choose chronic hepatitis B (light ~ moderate) patient's 126 examples of agreeing to accept this research method, take medicine of the present invention, wherein a weight portion is 1 dose, and every day, potion, one month was 1 course for the treatment of, after 6 courses for the treatment of, observe therapeutic effect, wherein effective 88 examples, effective 26 examples, invalid 12 examples, total effective rate reaches 90.5%, proves that medicine of the present invention has significant curative effect to chronic hepatitis B.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is described further.
Embodiment 1
Take Radix Bupleuri 10 g, Radix Paeoniae Rubra 10g, Radix Paeoniae Alba 10g, Radix Aucklandiae 5g, Fructus Schisandrae Chinensis 5g, Radix Et Rhizoma Rhei 10g, Herba Artemisiae Scopariae 10g, Fructus Lycii 10g, Squama Manis 10g, Carapax Trionycis 15g; Get 60% ethanol extraction 2 times that Squama Manis, Carapax Trionycis add 8 times, 6 times amounts, each 2 hours, merging filtrate, filter, concentrated, dry, pulverize to obtain alcohol extract, all the other each tastes add the water extraction 2 times of 8 times of amounts, each 2 hours, merging filtrate at every turn, filter, concentrated, after dry, pulverize, mix with alcohol extract.
Model case
?case 1
Deng, man, suffered from chronic hepatitis B before 10 years, weak, poor appetite, yellowish urine and abnormal liver function repeatedly, once seek medical advice diagnosis and treatment medication, all unsatisfactory curative effect of many places.Three Nian Laiwo institutes seek medical advice after being ill, patient at that time weak, poor appetite symptom is obvious, accompanies slight yellowish urine, dim complexion, looks into liver function moderate abnormal, five index of hepatitis b is great three positive, the HBV-DNA positive, B ultrasonic prompting liver parenchyma lesion ultrasonogram.Patient takes decoction for the treatment of the present invention 1 month, and liver function is just basic recovers normal; After 3 months, HBV-DNA the moon turns; After 6 months, great three positive turns small three positive.After 6 years, follow up a case by regular visits to still healthy living of patient.
Case 2
Teacher, male, main cause is weak, poor appetite 1 year, big belly meets the eye on every side Huang, and yellowish urine is admitted to hospital for more than 10 days.Before 1 year, patient chemically examines five indexes of hepatitis b at local hospital, HbsAg+, HbeAb+, HbcAb+, and liver function transaminase is higher than normally, and at local hospital symptomatic treatment, transaminase is repeatedly abnormal, checks liver function ALT1036u/L before 10 days, the further diagnosis and treatment of Lai Wo institute.Existing disease: dim complexion, white of the eye xanthochromia, abdominal distention poor appetite, yellowish urine icteric sclera, liver palm spider angioma, red tongue, yellow fur, stringy pulse.Human health screening: chronic hepatopathy face, whole skin, mucosa is slight xanthochromia, sclera moderate xanthochromia, cardiopulmonary no abnormality seen, under liver spleen rib not and, shifting dullness feminine gender, two lower limb are without edema, asterixis feminine gender, red tongue, yellow fur, stringy pulse.Lab testing: six of hepatitis B, HbsAg+, HbeAb+, HbcAb+, liver function: AST728u/L, ALT1069u/L, TbiL54.2ummol/L, anti-HBV-IgM feminine gender, HEV-IgG feminine gender, HEV-IgM feminine gender, HCV-IgG feminine gender, HCV-IgM feminine gender, is diagnosed as chronic hepatitis B.Patient took after 6 courses for the treatment of of medicine of the present invention, and it is normal that liver function is recovered substantially: AST26u/L, ALT36u/L, TbiL23.1mmol/L.After follow up a case by regular visits to check liver function all normal.
Case 3
Normal certain, man, patient is weak with repeatability, inappetence 3 years, increases the weight of to be chief complaint to examine for 1 year lab testing: hepatitis b virus marker: HbsAg (+), HbeAg (+), anti-HBc (+).2, liver function: ALT171u/L, AST120u/L.Be diagnosed as chronic hepatitis B.Take subsequently medicine of the present invention, take medicine continuously 3 months, ultrasound diagnosis liver morphosis is all normal.Take medicine continuously 4 months, except liver function is normal already, five indexes of hepatitis b: HbeAg is transferred to feminine gender and is produced antibody by the positive, and HBV-DNA also firmly turns out cloudy.This patient stop treatment after, followed up a case by regular visits at 6 months, 12 months and 18 months respectively, patient returns to one's perfect health.

Claims (2)

1. treat the Chinese medicine composition of chronic hepatitis B for one kind, it is characterized in that, be prepared from by the crude drug of following weight portion: Radix Bupleuri 10, Radix Paeoniae Rubra 10, the Radix Paeoniae Alba 10, the Radix Aucklandiae 5, Fructus Schisandrae Chinensis 5, Radix Et Rhizoma Rhei 10, Herba Artemisiae Scopariae 10, Fructus Lycii 10, Squama Manis 10, Carapax Trionycis 15.
2. the preparation method of Chinese medicine composition according to claim 1, is characterized in that, adopts and is prepared as follows method: take above each taste by proportioning, get 60% ethanol extraction 2 times that Squama Manis, Carapax Trionycis add 8 times, 6 times amounts, each 2 hours, merging filtrate, filter, concentrated, dry, pulverize to obtain alcohol extract, all the other each tastes add the water extraction 2 times of 8 times of amounts, each 2 hours at every turn, merging filtrate, filters, concentrated, after dry, pulverize, mix with alcohol extract.
CN201210293637.5A 2012-08-17 2012-08-17 Traditional Chinese medicine composition for treating chronic hepatitis B Expired - Fee Related CN102772575B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210293637.5A CN102772575B (en) 2012-08-17 2012-08-17 Traditional Chinese medicine composition for treating chronic hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210293637.5A CN102772575B (en) 2012-08-17 2012-08-17 Traditional Chinese medicine composition for treating chronic hepatitis B

Publications (2)

Publication Number Publication Date
CN102772575A CN102772575A (en) 2012-11-14
CN102772575B true CN102772575B (en) 2014-06-11

Family

ID=47117832

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210293637.5A Expired - Fee Related CN102772575B (en) 2012-08-17 2012-08-17 Traditional Chinese medicine composition for treating chronic hepatitis B

Country Status (1)

Country Link
CN (1) CN102772575B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181975A (en) * 2013-04-18 2013-07-03 范文中 Medicine for treating hepatitis and preparation method thereof
CN103933430B (en) * 2014-03-18 2016-11-23 吴侠 Chronic hepatitis B medicine and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160559A (en) * 1996-11-30 1997-10-01 李泽良 Hepatitis B curing toxin-dissipating pill

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160559A (en) * 1996-11-30 1997-10-01 李泽良 Hepatitis B curing toxin-dissipating pill

Also Published As

Publication number Publication date
CN102772575A (en) 2012-11-14

Similar Documents

Publication Publication Date Title
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN103007191A (en) Chinese medicinal composition for treating jaundice
CN102284050B (en) Chinese medicine composition for treating infertility caused by cold uterus
CN102526566B (en) Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method
CN102058784A (en) Medicinal composition for treating pulmonary heart disease and application thereof
CN102772575B (en) Traditional Chinese medicine composition for treating chronic hepatitis B
CN101745047A (en) Chinese medicinal composition for treating gout disease and preparation method thereof
CN102764337B (en) Traditional Chinese medicine composition for curing hepatitis B
CN103041301A (en) Traditional Chinese medicine composition for treating icterohepatitis
CN106309749A (en) Traditional Chinese medicine for treating cervical cancer
CN101417114B (en) Traditional Chinese medicine for treating hypertension and high blood-fat
CN103393909A (en) Chinese medicinal preparation for treating biliary calculus with cholecystitis
CN101015671B (en) Chinese patent drug for treating cirrhosis
CN102772595B (en) Traditional Chinese composition for treating chronic hepatitis B
CN102228643A (en) Traditional Chinese medicine composition for treating chronic prostatitis
CN102824482A (en) Traditional Chinese medicine composition for treating icteric hepatitis
CN103006833A (en) Medicine for hiatus hernia postoperative rehabilitation
CN103055072A (en) Traditional Chinese medicine composition for treating stranguria
CN102784212A (en) Chinese medicine composition for treating arthralgia-synadrome
CN102335243B (en) Chinese medicinal composition for treating icteric hepatitis
CN102430066B (en) Sciatic nerve liquid
CN101411856A (en) Medicament for treating osteoproliferation
CN101411859B (en) Chinese medicine preparation for treating dysmenorrhea
CN105194526A (en) Traditional Chinese medicine for treating hepatic calculi
CN102188669B (en) Medicament for treating cold-dampness obstruction syndrome and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140611

Termination date: 20160817